Taking Initiative to Optimize Lipid Lowering Therapy in High Risk Patients With ASCVD

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/NPY865. CME credit will be available until August 24, 2027. Taking Initiative to Optimize Lipid-Lowering Therapy in High-Risk Patients With ASCVD: A Call to Action for Cardiologists The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Cincinnati and PVI, PeerView Institute for Medical Education, are both accredited by the ACCME to provide continuing medical education for physicians and have collaborated to design and execute this activity. For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity. Support This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation. Disclosure information is available at the beginning of the video presentation.